Armata Pharmaceuticals, Inc. (ARMP)

[$5.95akadawson-m]

There was no news this morning - it was on March 10 and the funding has nothing to do with you call a "major investment fund." Check out what was written in the announcement:

AmpliPhi will use the proceeds from the fundraising to advance its three programs in methicillin-resistant staphylococcus aureus (MRSA), Pseudomonas aeruginosa infections in Cystic Fibrosis and Clostridium difficile. For its most advanced phage program, AmpliPhage-002 in MRSA, AmpliPhi intends to file an IND and commence Phase I clinical trials by year-end 2015. In its P. aeruginosa program (AmpliPhage-001) the Company expects to complete inhalation toxicology studies by the end of 2015. The Company's goal with respect to AmpliPhage-004 in C. difficile is to conclude pre-clinical efficacy studies during 2015.



Where did you get the idea of your claim? Please provide a link or don't spread disinformation.